chr6-131700503-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_030908.2(OR2A4):āc.899T>Cā(p.Leu300Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000088 ( 1 hom., cov: 7)
Exomes š: 0.000014 ( 4 hom. )
Failed GnomAD Quality Control
Consequence
OR2A4
NM_030908.2 missense
NM_030908.2 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 0.522
Genes affected
OR2A4 (HGNC:14729): (olfactory receptor family 2 subfamily A member 4) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
ENPP3 (HGNC:3358): (ectonucleotide pyrophosphatase/phosphodiesterase 3) The protein encoded by this gene belongs to a series of ectoenzymes that are involved in hydrolysis of extracellular nucleotides. These ectoenzymes possess ATPase and ATP pyrophosphatase activities and are type II transmembrane proteins. Expression of the related rat mRNA has been found in a subset of immature glial cells and in the alimentary tract. The corresponding rat protein has been detected in the pancreas, small intestine, colon, and liver. The human mRNA is expressed in glioma cells, prostate, and uterus. Expression of the human protein has been detected in uterus, basophils, and mast cells. Two transcript variants, one protein coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.05891484).
BS2
High Homozygotes in GnomAdExome4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2A4 | NM_030908.2 | c.899T>C | p.Leu300Ser | missense_variant | 1/1 | ENST00000315453.4 | NP_112170.1 | |
ENPP3 | NM_005021.5 | c.1412+6879A>G | intron_variant | ENST00000357639.8 | NP_005012.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2A4 | ENST00000315453.4 | c.899T>C | p.Leu300Ser | missense_variant | 1/1 | 6 | NM_030908.2 | ENSP00000319546.2 | ||
ENPP3 | ENST00000357639.8 | c.1412+6879A>G | intron_variant | 1 | NM_005021.5 | ENSP00000350265.3 | ||||
ENPP3 | ENST00000414305.5 | c.1412+6879A>G | intron_variant | 1 | ENSP00000406261.1 | |||||
ENPP3 | ENST00000358229.6 | c.1412+6879A>G | intron_variant | 1 | ENSP00000350964.5 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 5AN: 56468Hom.: 1 Cov.: 7 FAILED QC
GnomAD3 genomes
AF:
AC:
5
AN:
56468
Hom.:
Cov.:
7
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000752 AC: 16AN: 212890Hom.: 6 AF XY: 0.0000257 AC XY: 3AN XY: 116716
GnomAD3 exomes
AF:
AC:
16
AN:
212890
Hom.:
AF XY:
AC XY:
3
AN XY:
116716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000141 AC: 17AN: 1205822Hom.: 4 Cov.: 17 AF XY: 0.00000822 AC XY: 5AN XY: 608486
GnomAD4 exome
AF:
AC:
17
AN:
1205822
Hom.:
Cov.:
17
AF XY:
AC XY:
5
AN XY:
608486
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000885 AC: 5AN: 56512Hom.: 1 Cov.: 7 AF XY: 0.0000377 AC XY: 1AN XY: 26514
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
5
AN:
56512
Hom.:
Cov.:
7
AF XY:
AC XY:
1
AN XY:
26514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
10
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.899T>C (p.L300S) alteration is located in exon 1 (coding exon 1) of the OR2A4 gene. This alteration results from a T to C substitution at nucleotide position 899, causing the leucine (L) at amino acid position 300 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of disorder (P = 0.0031);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at